Right HeartWise
Pre Seed Round in 2025
Right HeartWise is a medical device company that develops patient-specific implantable right heart pumps to support right-sided heart failure. The pumps are non-motorized and self-powered, with no batteries or external cables, and are fully customized to each patient's anatomy. By eliminating bulky components, the device aims to improve comfort and mobility, enabling an active lifestyle with a focus on safety and ease of use.
RespiQ is a healthtech company developing portable, non-invasive breath analysis technology that uses emission spectroscopy and artificial intelligence to detect biomarkers in breath for early identification and real-time monitoring of respiratory diseases such as COPD, as well as other conditions like asthma, lung cancer, and infectious diseases. Its device aims to be affordable and user-friendly, democratizing access to advanced diagnostics, while its platform can also identify digestive issues through breath biomarkers and support personalized guidance via an app that analyzes a digital breath print to deliver diet and health insights, enabling individuals to monitor changes and improve health outcomes.
Vésale Pharma
Grant in 2022
Vésale Pharma collaborates with renowned global research institutions to develop innovative healthcare solutions tailored for diverse populations. Their product portfolio spans dermatology, gastroenterology, women's health, immunity, and pregnancy, aiming to enhance overall well-being without adverse side effects.
VIVAN Therapeutics
Grant in 2022
VIVAN Therapeutics pioneers personalized cancer therapeutics using innovative assay technology. It licenses technology from the Center for Personalized Cancer Therapeutics at Mount Sinai New York, offering a comprehensive, genomics-based drug screening service enabled by blockchain. The company's approach intelligently designs personalized treatments, combining cancer and non-cancer drugs to reduce toxicity and cost.
Brainhero offers home-based neurofeedback therapy using EEG technology. It aims to help children manage symptoms of Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) through engaging, app-based brain training.
Restore Medical
Grant in 2022
Restore Medical develops a device-based therapy for congestive heart failure. Its product, ContraBand, is a catheter-delivered implant in the pulmonary arteries designed to improve patient quality of life and reduce hospital readmission rates.
NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.
Askel Healthcare
Grant in 2021
Askel is a medical technology company specializing in knee cartilage repair. Its innovative device aims to enhance recovery, prevent osteoarthritis, reduce healthcare costs, and facilitate swift rehabilitation.
Xsensio
Seed Round in 2021
Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.
AVeta Medical
Grant in 2021
AVeta Medical develops hormone-free, safe, and affordable biotechnology medical devices for treating underlying conditions of vaginal atrophy. Their innovative solutions target symptoms and restore tissue health naturally, providing long-term benefits with easy-to-use treatments.
PKvitality
Series A in 2021
PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.
NanoVation
Venture Round in 2021
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.
Mode Sensors
Venture Round in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.
Mode Sensors
Grant in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.
moveUP
Venture Round in 2020
moveUP develops digital therapeutics solutions, focusing on improving patient engagement and streamlining healthcare delivery. Its closed-loop system ensures high compliance and better outcomes by continuously collecting data to personalize treatment. Currently, it offers a therapy for orthopaedic patients undergoing joint surgery, with CE medical device certification.
Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.
Klikkit is a welfare technology platform founded in 2018, focused on enhancing care in home care, care homes, and hospitals. The company develops a personal habits monitoring application designed to help users track, analyze, and improve their daily behaviors. This mobile application provides scheduling and discreet notifications for essential tasks, presents data in organized charts and graphs, and offers an overview of progress across various activities. By enabling users to assess their habits and make necessary adjustments, Klikkit supports the cultivation of good and healthy habits, ultimately promoting a better lifestyle.
PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.
Klikkit
Venture Round in 2020
Klikkit is a welfare technology platform founded in 2018, focused on enhancing care in home care, care homes, and hospitals. The company develops a personal habits monitoring application designed to help users track, analyze, and improve their daily behaviors. This mobile application provides scheduling and discreet notifications for essential tasks, presents data in organized charts and graphs, and offers an overview of progress across various activities. By enabling users to assess their habits and make necessary adjustments, Klikkit supports the cultivation of good and healthy habits, ultimately promoting a better lifestyle.
Xsensio
Venture Round in 2020
Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.
moveUP develops digital therapeutics solutions, focusing on improving patient engagement and streamlining healthcare delivery. Its closed-loop system ensures high compliance and better outcomes by continuously collecting data to personalize treatment. Currently, it offers a therapy for orthopaedic patients undergoing joint surgery, with CE medical device certification.
Picterus is developing an app to diagnose jaundice in newborns, aiming to reduce the global infant mortality associated with this condition. The platform uses a patented color calibration card and smartphone camera for accurate image capture, providing healthcare professionals and caregivers with a reliable tool for early detection and timely intervention.
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.
Picterus
Venture Round in 2019
Picterus is developing an app to diagnose jaundice in newborns, aiming to reduce the global infant mortality associated with this condition. The platform uses a patented color calibration card and smartphone camera for accurate image capture, providing healthcare professionals and caregivers with a reliable tool for early detection and timely intervention.
NanoVation
Venture Round in 2019
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.